| LRPPRC mutations cause early-onset multisystem mitochondrial disease outside of the French-Canadian population M Oláhová, SA Hardy, J Hall, JW Yarham, TB Haack, WC Wilson, ... Brain 138 (12), 3503-3519, 2015 | 106 | 2015 |
| A human mitochondrial poly (A) polymerase mutation reveals the complexities of post-transcriptional mitochondrial gene expression WC Wilson, HT Hornig-Do, F Bruni, JH Chang, AA Jourdain, JC Martinou, ... Human molecular genetics 23 (23), 6345-6355, 2014 | 82 | 2014 |
| Dnmt3a regulates T-cell development and suppresses T-ALL transformation AC Kramer, A Kothari, WC Wilson, H Celik, J Nikitas, C Mallaney, ... Leukemia 31 (11), 2479-2490, 2017 | 54 | 2017 |
| JARID2 functions as a tumor suppressor in myeloid neoplasms by repressing self-renewal in hematopoietic progenitor cells H Celik, WK Koh, AC Kramer, EL Ostrander, C Mallaney, DAC Fisher, ... Cancer cell 34 (5), 741-756. e8, 2018 | 49 | 2018 |
| Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types. SR Amend, WC Wilson, L Chu, L Lu, P Liu, D Serie, X Su, Y Xu, D Wang, ... PloS one 10 (5), e0127828, 2015 | 36 | 2015 |
| Collaborative control of cell cycle progression by the RNA exonuclease Dis3 and Ras is conserved across species MJ Snee, WC Wilson, Y Zhu, SY Chen, BA Wilson, C Kseib, J O’Neal, ... Genetics 203 (2), 749-762, 2016 | 30 | 2016 |
| AO-176, a highly differentiated clinical stage anti-CD47 antibody, exerts potent anti-tumor activity in preclinical models of multiple myeloma as a single agent and in … WC Wilson, J Richards, RJ Puro, G Andrejeva, BJ Capoccia, MJ Donio, ... Blood 136, 3-4, 2020 | 12 | 2020 |
| Deletion of Rb1 induces both hyperproliferation and cell death in murine germinal center B cells Z He, J O'Neal, WC Wilson, N Mahajan, J Luo, Y Wang, MY Su, L Lu, ... Experimental hematology 44 (3), 161-165. e4, 2016 | 9 | 2016 |
| The GNASR201C mutation associated with clonal hematopoiesis supports transplantable hematopoietic stem cell activity EL Ostrander, WK Koh, C Mallaney, AC Kramer, WC Wilson, B Zhang, ... Experimental hematology 57, 14-20, 2018 | 6 | 2018 |
| High‐throughput assays for assessing mitochondrial dysfunction caused by compounds that impair mtDNA‐encoded protein levels in eukaryotic cells S Nadanaciva, J Murray, C Wilson, DF Gebhard, Y Will Current protocols in toxicology 48 (1), 3.11. 1-3.11. 17, 2011 | 6 | 2011 |
| Highly differentiated anti-CD47 antibody, AO-176, potently inhibits hematologic malignancies alone and in combination J Richards, MN Bouchlaka, RJ Puro, BJ Capoccia, RR Hiebsch, MJ Donio, ... Blood 134, 1844, 2019 | 3 | 2019 |
| Combination therapy for the treatment of solid and hematological cancers M Donio, PT Manning, P Robyn, JC Almagro, BJ CAPOCCIA, ... US Patent App. 17/726,683, 2022 | 2 | 2022 |
| Pre-clinical combination of AO-176, a highly differentiated clinical stage CD47 antibody, with either azacitidine or venetoclax significantly enhances DAMP induction and … MJ Donio, WC Wilson, I Darwech, G Andrejeva, BJ Capoccia, RJ Puro, ... Blood 136, 9-10, 2020 | 2 | 2020 |
| Therapeutic potential of AO-176, a next generation humanized CD47 antibody, for hematologic malignancies WC Wilson, MN Bouchlaka, BJ Capoccia, RR Hiebsch, MJ Donio, ... Blood 132 (Supplement 1), 4180-4180, 2018 | 2 | 2018 |
| Development of AO-176, a next generation humanized anti-CD47 antibody with novel anti-cancer properties and negligible binding to red blood cells MN Bouchlaka, R Puro, B Capoccia, M Donio, R Hiebsch, AJ Carter, ... Eur J Cancer 103, 76, 2018 | 2 | 2018 |
| Evaluation of a model clinical therapeutics curriculum for physician assistant and nurse practitioner education in the United States N Whitman, W Wilson Pharmacy Education 1 (3), 2001 | 2 | 2001 |
| A Survey of Opinions on the Training of Teachers of Exceptional Children. WV Schipper, WC Wilson | 2 | 1975 |
| Cost analysis comparison between anterior and posterior cervical spine approaches AY Chan, AS Himstead, EH Choi, Z Hsu, JS Kurtz, C Yang, YP Lee, ... Surgical Neurology International 13, 2022 | 1 | 2022 |
| AO-176, a differentiated clinical-stage anti-CD47 antibody, demonstrates potent anti-tumor activity across multiple preclinical models of b cell neoplasms WC Wilson, JO Richards, G Andrejeva, BJ Capoccia, RJ Puro, MJ Donio, ... Blood 138, 2277, 2021 | 1 | 2021 |
| Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients M Camilleri, T McGrath, W Wilson, SJ Ings, J Horder, F Newrick, J Sive, ... Leukemia & Lymphoma 62 (12), 3023-3026, 2021 | 1 | 2021 |
Michael TomassonProfessor, University of IowaVerified email at uiowa.edu
